Related Experiment Video
Updated: Oct 30, 2025

Biobank for Translational Medicine: Standard Operating Procedures for Optimal Sample Management
Published on: November 30, 2022
United Kingdom Biobank (UK Biobank): JACC Focus Seminar 6/8
Rishi Caleyachetty1, Thomas Littlejohns1, Ben Lacey1
1Big Data Institute, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.
Insights
Cardiovascular disease (CVD) research requires comprehensive data. UK Biobank provides a vast resource of multiomics, lifestyle, and health records for millions, advancing chronic disease understanding.
Area of Science:
- Biomedical Research
- Population Health Science
- Genomic Epidemiology
Background:
- Cardiovascular disease (CVD) prevalence is rising, increasing healthcare demands.
- Optimal cardiovascular care necessitates population-based biobanks with multiomics, phenotype, and lifestyle data.
- UK Biobank is a major UK cohort study established between 2006-2010.
Purpose of the Study:
- To highlight the UK Biobank as a critical resource for cardiovascular disease research.
- To emphasize the value of integrated multiomics, imaging, and electronic health record data.
- To support research aimed at preventing, diagnosing, and treating chronic conditions, including CVD.
Main Methods:
- Recruitment of over half a million UK individuals aged 40-69.
- Collection of data on multiomics (genomics, metabolomics, proteomics), imaging, lifestyle factors, and health outcomes.
- Linkage to electronic health records for comprehensive health information.
Main Results:
- UK Biobank is one of the world's largest and most accessible in-depth cohort studies.
- The resource is continuously enhanced with diverse omics data, imaging, and linked health records.
- Facilitates extensive research into chronic diseases.
Conclusions:
- UK Biobank is an invaluable asset for advancing cardiovascular disease research.
- The integrated data resource supports a broad spectrum of biomedical research.
- Enables researchers to investigate and combat chronic diseases effectively.
Abstract:
An increasing number of people are now living with cardiovascular disease (CVD), with concomitant CVD-related hospitalizations, operations, and prescriptions. To ultimately deliver optimal cardiovascular care, access to population-based biobanks with data on multiomics, phenotypes, and lifestyle risk factors are crucial. UK Biobank is a cohort study that incorporated data between 2006 and 2010 from over half a million individuals (40 to 69 years of age) at recruitment from across the United Kingdom. As one of the most accessible, largest, and in-depth cohort studies in the world, UK Biobank continues to enhance the resource with the addition of data from various omics platforms (eg, genomics, metabolomics, proteomics), multimodal imaging, self-reported risk factors and health outcomes, and linkage to electronic health records. The vision of UK Biobank is to allow as many researchers as possible to apply their expertise and imagination to undertake research to prevent, diagnose, and treat a wide range of chronic conditions, including CVD.
Related Concept Videos
Bioremediation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Healthcare Agencies II
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources,...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Healthcare Agencies I

